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An effective type I interferon (IFN-α/β) response is critical for the control of many viral infections. Using an oncolytic strain of vesicular
stomatitis virus, we have examined the cross-talk between virus-induced apoptosis and initiation of innate immune response. The intrinsic
apoptotic cascade, specifically the Bax-Bcl-2-Caspase-9 cascade, was revealed as the primary pathway of VSV-induced apoptosis. Cell death was
significantly reduced in BaxBak−/− murine embryonic fibroblasts (MEFs) and in human A549 epithelial cells treated with siRNA against Bax.
Although inhibition of apoptosis resulted in enhanced virus replication in the BaxBak−/− MEFs as compared to wild-type cells, induction of the
IFN antiviral response and expression of cytokine genes were attenuated in virus-infected cells. Moreover, Bax but not Bak pro-apoptotic protein
was required for IRF-3 phosphorylation and activation, further substantiating a role for the intrinsic mitochondrial pathway in the innate immune
response. Therefore, virus-induced apoptosis through a Bax-dependent mitochondrial pathway appears to enhance the full development of the
IRF-3 mediated IFN antiviral response.
© 2007 Elsevier Inc. All rights reserved.Keywords: Mitochondria; IRF-3; Innate immunity; VSV; BaxIntroduction
Apoptosis represents an evolutionary conserved pathway that
is important for development, cellular homeostasis, and cellular
defense against microbial and viral pathogens (Opferman and
Korsmeyer, 2003). The mitochondria represent a central cross-
road, where pro- and anti-apoptotic signals are integrated (Green
and Kroemer, 2004). Following an apoptotic trigger, mito-
chondria undergo loss of inner mitochondrial membrane
potential and subsequent mitochondrial membrane perme-
abilization (MMP) and release of death-promoting factors such
as cytochrome c, SMAC/Diablo, and endonuclease G (Wang,⁎ Corresponding author. Lady Davis Institute for Medical Research, 3755
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doi:10.1016/j.virol.2007.03.0112001). The mitochondrial-mediated apoptotic cascade is tightly
regulated by members of the Bcl-2 family (Cory et al., 2003;
Ruffolo and Shore, 2003). Antiapoptotic members of the Bcl-2
family, such as Bcl-xL and Bcl-2, prevent Bax and Bak
oligomerization, thereby interfering with cytochrome c release
(Gross et al., 1999; Scorrano and Korsmeyer, 2003). Among
the pro-apoptotic members, small BH3-only proteins such as
Bid, Bad, Noxa, and Puma may initiate the death signal,
whereas the multidomain proteins Bax and/or Bak are required
for commitment to cell death via the mitochondrial pathway
(Cheng et al., 2001). In viable cells, Bax and Bak exist as
inactive monomers in the cytosol or loosely attached to mem-
branes; in response to a variety of death stimuli, Bax/Bak
insert into the outer mitochondrial membrane as homo-
oligomerized multimers (Griffiths et al., 1999; Gross et al.,
1998). Consequently, the release of cytochrome c from the
mitochondria activates the Apaf-1/caspase-9 apoptosome and
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irreversible cell death. Loss of both Bax and Bak therefore
results in profound resistance to many apoptotic stimuli,
including death receptor signaling and genotoxic agents (Zong
et al., 2001; Degenhardt et al., 2002).
To inhibit apoptosis, many viruses encode proteins that
function directly at the mitochondrial level (Boya et al.,
2001). In fact, apoptosis is an innate defense mechanism to
intracellular pathogen infection. In the course of evolution,
many viruses have acquired the ability to encode products
that interfere with the mitochondrial-dependent apoptotic
pathway for their own benefit (Everett and McFadden,
2001; Hardwick and Bellows, 2003). For example, M11L, a
myxoma-virus encoded antiapoptotic protein, blocks apopto-
sis by preventing Bax conformational change (Su et al.,
2006). Similarly, E1B 19K from adenovirus interacts with and
blocks Bax and Bak oligomerization to inhibit mitochondrial
induced cell death (Perez and White, 2000; Sundararajan et
al., 2001). Vaccinia virus, a member of the poxvirus family,
encodes an anti-apoptotic protein, F1L that interacts with Bak
and inhibits its activation (Wasilenko et al., 2005). Karposi's
sarcoma-associated herpesvirus (KSHV) encodes a viral K7
protein that contains a portion of a baculovirus inhibitor of
apoptosis repeat domain and putative BH2 domain (Wang et
al., 2002). Following KSHV infection, K7 localizes to the
mitochondria and interacts with activated caspase 3, Bcl-2,
and calcium-modulating cyclopilin ligand, resulting in the
regulation of cellular calcium levels and inhibition of
apoptosis (Feng et al., 2002). In the context of VSV infection,
it was recently demonstrated that M protein contains a
mitochondrial targeting motif and inserts into the mitochon-
drial membrane (Lichty et al., 2006).
A major consequence of virus infection is the induction of
the type I interferons (IFNs), a family of cytokines essential
for the development of innate and adaptive defense (Hiscott et
al., 2006b; Honda and Taniguchi, 2006; Nakhaei et al., 2006;
Stetson and Medzhitov, 2006). Activation of the ubiquitous
transcription factor interferon regulatory factor 3 (IRF-3) is
critical for the initiation of the IFN antiviral response. The
IKK-related kinases TBK1 and IKKε function as essential
components of the virus-activated complex that phosphorylate
and activate IRF-3, as well as the closely related IRF-7
(Fitzgerald et al., 2003; Sharma et al., 2003). A unique
cytoplasmic signaling pathway utilizes the retinoic acid indu-
cible gene I (RIG-I) to recognize a variety of RNA viruses
and trigger the innate antiviral response (Yoneyama et al.,
2004). A link between RIG-I dependent innate immune
response and the mitochondria was recently established.
Several groups identified a novel CARD domain-containing
adapter molecule – mitochondrial antiviral response (MAVS)/
interferon-β stimulator 1 (IPS-1)/virus induced signaling
adapter (VISA)/CARD-domain containing IFN inducer (Car-
dif) – involved in RIG-I-dependent signaling to the IKKα/β
complex and to TBK1/IKKε (Kawai et al., 2005; Meylan et
al., 2005; Seth et al., 2005; Xu et al., 2005). MAVS/IPS-1/
VISA/Cardif functions as a critical adapter molecule between
early detection of virus infection by RIG-I and downstreamsignaling events leading to IFN production (Seth et al., 2005;
Xu et al., 2005). In addition, Seth et al. showed that the
knockdown of MAVS using siRNA resulted in the partial
cleavage of the apoptosis marker Poly (ADP-ribose) poly-
merase (PARP), thus suggesting a role for MAVS/IPS-1/
VISA/Cardif in the inhibition of apoptosis. Thus, it seems
likely that events at the RIG-I-MAVS-IKKε mitochondrial
complex may influence both the host antiviral response and
virus-induced apoptosis (Hiscott et al., 2006a). The successful
propagation of virus is therefore intertwined with its ability to
overcome apoptosis, as well as the host innate and adaptive
immune response.
VSV, the prototypic member of the family Rhabdoviridae, is
an enveloped virus with a single negative strand genomic RNA.
Intriguingly, VSV is exquisitely sensitive to IFN antiviral
response, thus making this virus unable to replicate efficiently
in normal cells in vitro and in vivo (Balachandran and Barber,
2000; Ebert et al., 2003; Fernandez et al., 2002; Lichty et al.,
2004; Stojdl et al., 2000; Stojdl et al., 2003). However the
oncolytic capacity of VSV resides with its selective ability to
replicate in a variety of cancer cells in vitro and to target and
destroy tumor cells in immunocompetent animal models in vivo
(Balachandran and Barber, 2000; Ebert et al., 2003; Fernandez
et al., 2002; Lichty et al., 2004; Stojdl et al., 2003). For
example, VSV infection selectively killed a large panel of
human tumor cell lines including 80% of the NCI 60 tumor cell
bank, cleared bone marrow of leukemic AML cells and
effectively arrested metastatic spread of CT26 lung metastases
in immunocompetent animals (Fernandez et al., 2002; Stojdl et
al., 2000, 2003).
VSV induces mitochondrial dependent apoptosis in a
caspase-9/Apaf-1 dependent manner, in part through the viral
matrix M protein, which shuts off host mRNA export from
the nucleus via interaction with the Nup98 and Rae1 nuclear
pore complex proteins (Balachandran et al., 2001; Enninga et
al., 2002; Faria et al., 2005; Fontoura et al., 2005; Gadaleta
et al., 2005; Kopecky and Lyles, 2001; Von Kobbe et al.,
2000). The export block leads to depolarization of the
mitochondrial membrane as well as release of cytochrome c
and AIF (Gadaleta et al., 2005; Modjtahedi et al., 2006).
Stojdl et al. characterized natural IFN-inducing VSV variants
(AV1 and AV2) with single point mutations in the M protein
that decrease the ability of the M protein to block host
mRNA nuclear export, in part due to impaired interactions
with Nup98 and Rae1 (Faria et al., 2005; Stojdl et al., 2003;
Von Kobbe et al., 2000). As a consequence, AV1 and AV2
have an improved therapeutic index as oncolytic agents
compared to wild type VSV (Gaddy and Lyles, 2007; Stojdl
et al., 2003).
The current study was therefore undertaken to understand
further the molecular pathways regulating VSV-induced
apoptosis and to establish a link between MMP and trig-
gering of IFN antiviral response. This report demonstrates
that Bax/Bak-dependent mitochondrial apoptotic pathway
represents a major component required for the initiation of
VSV-induced cell death and enhancement of the IFN anti-
viral response.
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Requirements for VSV-induced apoptosis
In many cell types including numerous tumor cells, there is
coordination and cross talk between the extrinsic and intrinsic
apoptotic cascades in the initiation of apoptosis (Danial and
Korsmeyer, 2004; Opferman and Korsmeyer, 2003). Thus, we
first sought to investigate the involvement of the extrinsic or
intrinsic cell death pathways in VSV-induced apoptosis (Fig.
1A). VSV replication and the loss of mitochondrial trans-
membrane potential (Δψm) occurred to similar levels in wild-
type (WT), FADD negative or caspase-8 negative Jurkat cells,
demonstrating that the extrinsic apoptotic pathway was not the
main pathway for VSV-induced cell death or proteolytic
activation of caspase 3 regardless of strain of VSV virus usedFig. 1. Caspase-8 and FADD are not involved in AV1 VSV-mediated cell death. A: S
represent interactions that do not appear to play a major role in the initiation of VSV-
Jurkat cells, or Jurkat cells negative for caspase-8 or negative of FADD molecule we
VSV replication, caspase-3 activation, and RhoGDI processing were analyzed in total
cleaved caspase-3 and Rho-GDI are indicated. β-Actin was included as a loading c(VSV-AV1 or HR) (Fig. 1B and Supplementary Figs. 1 and 2).
Since the BH3-only proapoptotic protein BID links the
extrinsic pathway to the mitochondria (Luo et al., 1998),
mouse embryonic fibroblasts (MEF) deficient in BID (Bid−/−)
were used to further assess the link between the extrinsic and
the mitochondrial-dependent intrinsic pathway in the initiation
of VSV-mediated apoptosis. No differences in the kinetics of
cell death induction or mitochondrial depolarization were
observed in Bid−/− MEFs compared to WT MEFs (Supple-
mentary Fig. 3).
These results implied that the intrinsic apoptotic pathway was
involved in VSV-induced cell death. Therefore caspase-9−/−
MEFs or caspase-2/9−/− double knockout MEFs were used
to determine whether blocking the intrinsic pathway would
affect VSV-induced apoptosis. Compared with WT MEFs,
caspase-9−/− or caspase-2/9−/− MEFs appeared morphologicallychematic of the extrinsic and intrinsic apoptotic signaling pathway. Dotted lines
mediated apoptosis. See text for details. Casp., Caspase; tBid, truncated Bid. B:
re infected with VSV-AV1 strain at an MOI of 1 pfu/cell at the indicated times.
lysates. The position of VSV proteins (G, N, andM), and the molecular weight of
ontrol.
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(Fig. 2A). Recombinant VSV expressing GFP was used to
examine cell death in individual cells infected with VSV.
Microscopically, WT MEFs infected with VSV-GFP showed
an apoptotic phenotype (Fig. 2B), whereas no cell death was
observed in caspase-9−/− or caspase-2/9−/− MEFs infected
with VSV-GFP. Quantification of virus replication by pla-
que assay revealed that the yield of infectious virus in
caspase-9−/− and caspase-2/9−/− MEFs were comparable toFig. 2. Absence of caspase-9 inhibits VSV-AV1-induced cell death. A: MEFs from
morphology was monitored microscopically at 16 h post-infection in mock- versus VS
caspase-9−/−, or caspase-2/9−/− were infected with recombinant VSV-GFP virus (MO
Zeiss inverted microscope. Representative fluorescence images taken with a 40× o
VSV-infected MEFs were collected and plaque assays for viral quantification were p
were analyzed in WCE from WT, caspase-9−/−, or caspase-2/9−/− VSV-infected ME
cleaved caspase-3 are indicated, with β-actin included as a loading control. ResultsWT MEFs (Fig. 2C). Immunoblot analysis of lysates from WT,
caspase-9−/−, caspase-2/9−/− MEFs demonstrated that VSV
replication was not inhibited by blocking the intrinsic apoptotic
pathway (Fig. 2D, upper panel). In contrast, a delay in the
accumulation of active caspase-3 was detected in caspase-9−/−
cells (Fig. 2D, middle panel). In WTMEFs, accumulation of the
active caspase-3 form (p19) was detected at 6 h, whereas, in
caspase-9−/− MEFs, caspase-3 activation was delayed to 16 h
post-infection. Under similar conditions, activation ofWT, caspase-9−/−, or caspase-2/9−/− were infected with VSV-AV1 and cell
V-infected cultures. Images were taken with a 40× objective. B: MEFs fromWT,
I 1 pfu/cell). Cell death in infected, GFP-expressing cells was monitored using
bjective are shown. C: Supernatants from WT, caspase-9−/−, or caspase-2/9−/−
erformed on confluent Vero cells. D: VSV replication and caspase-3 activation
Fs. The position of VSV proteins (G, N, and M), and the molecular weight of
are representative of two separate experiments.
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(Fig. 2D, right panel). Taken together, these results specify a
central role for intrinsic apoptotic pathway in VSV-mediated
cell death.Bax activity is required for VSV-induced apoptotic signaling
Mitochondrial apoptotic signaling was next examined in
BaxBak−/− MEFs (Wei et al., 2001). As with caspase-9−/−
Fig. 3. Bax deficiency impairs VSV-mediated cell death. A: MEFs fromWT, BaxBak−/− were infected with VSV-AV1 at MOI of 0.1, 1, 10, or 100 pfu/cell. Cell death
was monitored microscopically at 16 h post-infection and photographed with a 40× objective. B: WTor BaxBak−/−MEFs were harvested 16 h post-infection and DNA
content was determined by PI staining. The software CellQuest was used to determine the percentage of cells in the sub-G1 phase of the cell cycle post-infection. C:
The shift in the mitochondrial transmembrane potential was quantified by flow cytometry using JC-1 staining. D: VSV replication and caspase-3 activation were
analyzed in WCE from VSV-infected MEFs. The position of VSV proteins (G, N, and M), and the molecular weight of cleaved caspase-3 are indicated. β-Actin was
included as a loading control. E: Supernatants from WT or BaxBak−/− VSV-infected MEFs were collected every 2 h post-infection and a plaque assay for infectious
viral particles was performed using confluent Vero cells. F: WT or BaxBak−/− MEFs were infected with VSV-AV1 or VSV-HR and harvested 12 and 24 h post-
infection to measure caspase-3 activity using DEVDase assay. Results are representative of three separate experiments. G: VSV replication and caspase-3 activation
were analyzed in WCE from Bax−/− or Bak−/−MEFs. The position of VSV proteins (G, N, and M), and the molecular weight of cleaved caspase-3 are indicated.
β-Actin was included as a loading control. Results are representative of three separate experiments.
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ability of VSV to induce microscopic apoptosis, even at MOI
100 (Fig. 3A). In parallel, BaxBak−/− MEFs were examined for
DNA content and MMP activity; the absence of Bax/Bak
inhibited DNA condensation and fragmentation (Fig. 3B), and
blocked the ability of VSV to induce rapid MMP loss (Fig. 3C)
as compared to WT MEFs. Surprisingly, the level of VSV
replication was substantially increased in BaxBak−/− as
compared to WT MEFs; yet, the proteolytic caspase-3 cleavage
was delayed in these cells (12 vs 6 h) (Fig. 3D). A plaque assay
was used to distinguish whether the increase in VSV proteins
was due to the accumulation of viral proteins in surviving cells
or to an enhancement of viral replication; a 10-fold increase in
virus yield was detected in BaxBak−/− MEFs 16 h post-VSV
infection (4.5×105 pfu/ml), compared to the yield in WTMEFs
(4.2×104 pfu/ml) (Fig. 3E). Similar results were observed in
BaxBak−/− and WT MEFs infected with VSV-HR (Supplemen-
tary Fig. 4). A caspase-3 fluorometric activity assay demon-
strated an 8-fold increase in caspase-3 activity in WT MEFs
infected with VSV-AV1 compared to BaxBak−/− MEFs;
similarly, a 4-fold increase in caspase-3 activity was observed
in WT MEFs infected with VSV-HR compared to BaxBak−/−
MEFs (Fig. 3F). Finally, the relative requirement for Bax and/or
Bak pro-apoptotic proteins was determined. As illustrated in
Fig. 3G, Bax but not Bak deficiency inhibited VSV-induced cell
death, thus providing a link between Bax but not Bak
proapoptotic protein and the ability of VSV to initiate apoptosis.
Impaired antiviral responsive gene induction in the absence of
BaxBak
Given the robust replication of VSV detected in MEFs
lacking Bax/Bak, we next sought to determine whether Bax-
Bak deficiency would modulate the host response to virus
infection. RNA from WT and BaxBak−/− MEFs was examined
by microarray analysis using a murine cDNA array containing15,000 unique genes. A reduction in the expression of several
key IFN-inducible genes was detected at 12 h post infection in
the BaxBak−/− MEFs (Fig. 4A). Importantly, attenuation in the
expression of IFNα genes, particularly Ifnα4, Ifnα5, Ifnα6,
Ifnα7, and Ifnα11 was detected in BaxBak deficient but not
in WT MEFs (Fig. 4B). The impairment of IFN gene
activation in the absence of Bax/Bak was confirmed at the
mRNA level by RT-PCR; as shown in Fig. 4C, RT-PCR
analysis revealed that the expression of antiviral genes was
decreased 2–13 fold in BaxBak−/− MEFs (Fig. 4C, lower
panel and 4D) compared to that of WT MEFs (Fig. 4C, upper
panel and 4D). These results indicate that the high level of
VSV replication in BaxBak−/− MEFs was a consequence of
the decreased production of type I IFN in these cells.
Diminished IRF-3 phosphorylation in VSV-infected
BaxBak-deficient MEFs
Since virus-induced IRF-3 activation by phosphorylation is
necessary for IFN gene induction (Lin et al., 1998; Yoneyama
et al., 1998), IRF-3 activation in BaxBak−/− MEFs was next
investigated. Upon phosphorylation at the carboxyl terminus,
the migration of IRF-3 on SDS-PAGE is reduced, resulting in
the detection of slowly migrating phosphorylated forms.
Following VSV infection, weak induction of forms III and IV
was detected in BaxBak−/− MEFs, whereas in WT MEFs a
strong shift of IRF-3 to forms III and IV was observed by 8 h
post-infection (Fig. 5A). Nuclear extracts prepared from
infected MEFs (Fig. 5B) demonstrated that translocation of
phosphorylated IRF-3 was diminished in BaxBak−/− but not
in WT MEFs. Furthermore, EMSA analysis of IRF-3 in
BaxBak−/− MEFs demonstrated that an IRF-3-DNA binding
complex was induced 8 h post-VSV infection in WT MEFs
(Figs. 5C and D), whereas the amount of IRF-3–DNA
complex formed in BaxBak−/− MEFs was reduced (Figs. 5C
and D), indicating diminished IRF-3 binding in the absence
Fig. 4. Reduced antiviral responsive gene expression in BaxBak−/− MEFs. A: WT or BaxBak−/− MEFs were infected with VSV-AV1 strain at an MOI of 1 pfu/cell.
Cells were collected 12 h post-infection and microarray analysis was performed. The name of the gene abbreviation (GS), and the ratio of expression in WT vs
BaxBak-deficient MEFs are indicated. B: WT or BaxBak−/−MEFs were infected with VSV-AV1 for various times as in A. Kinetics of IFN-α4, -α5, -α6, -α7, and -α11
levels of expression were obtained by microarray analysis and plotted versus time post-VSV infection. C: WTor BaxBak−/−MEFs were infected as in A. RT-PCR was
performed on indicated genes from total RNA 12 h post-VSV infection. Products were revealed using Amersham Typhoon phosphoimager. D: Expression levels were
normalized to GAPDH and fold increases in antiviral gene expression were determined in WT versus BaxBak−/− MEFs at 12 h post-infection. Results are
representative of two separate experiments.
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27E. Sharif-Askari et al. / Virology 365 (2007) 20–33of mitochondrial-dependent cell death, regardless of viral
replication. Next, the contribution of Bax and Bak proteins
was determined; EMSA analysis revealed that the formation
of the specific IRF-3–DNA complex was reduced in the
absence of Bax (Fig. 5F) but not Bak (Fig. 5E). In contrast,
EMSA analysis demonstrated strong NF-κB DNA binding
activity in both the WT and BaxBak−/− MEFs, indicating that
the inhibition of IRF-3 binding activity was specific and not a
generalized effect in BaxBak−/− MEFs (Fig. 5G).
Diminished IRF-3 phosphorylation in VSV-infected Bax
knock-down A549 cells
Next, we sought to determine if the siRNA knock-down
of Bax in human A549 epithelial cells would affect IRF3
phosphorylation following VSV infection. A549 cells were
treated with specific siRNA targeting Bax and 48 h later
infected with VSV-AV1. Bax siRNA knock-down in A549
cells resulted in diminished IRF3 phosphorylation following
virus infection and resulted in the enhancement of VSV
replication (Fig. 6A). In addition, apoptotic cell death was
decreased in Bax knock-down A549 cells infected with
VSV-AV1 (Fig. 6B).
Overexpression of Bax confers IRF-3 binding activity
Because the absence of Bax resulted in diminished IRF-3
phosphorylation and DNA binding following VSV infection,
we asked whether Bax overexpression would induce IRF-3
binding activity in the absence of viral infection. Over-
expression of murine Bax protein induced cell death (Fig.
7A), and MMP loss (Fig. 7B) at 48 h post-transfection.
Concomitant with the induction of cell death, IRF-3–DNA
binding complex was detected by EMSA in extracts from
mBax transfected but not in control lysates (Fig. 7C), indicating
that Bax-mediated MMP and apoptosis contributes to enhance
the induction of IRF-3 activity.
Discussion
The emergence of VSV as a potential therapeutic anticancer
agent has stimulated interest in the relationship between the
mechanisms of VSV induced apoptosis and the initiation of
the host antiviral response. Within this context, the present
study has addressed the role of cross-talk between apoptosis
and antiviral pathways in the full development of the innate
host response to virus infection (Hiscott et al., 2006a). Our
results demonstrate that regardless of the VSV strain – wild-
type Indiana or the naturally attenuated AV1 – both viruses
require the mitochondrial-dependent pathway of apoptosis to
induce programmed cell death, irrespective of the initial trig-
gering of the intrinsic or extrinsic apoptotic pathway. Fur-
thermore, the proapoptotic protein Bax is an early activator
of the mitochondrial depolarization triggered by VSV
replication. Inhibition of VSV-mediated MMP in BaxBak−/−
MEFs resulted in the impaired development of the host
antiviral response. These data establish a link between Bax-dependent MMP and full development of the host antiviral
response.
The mitochondrial pathway is regulated by both proapopto-
tic and antiapoptotic members of the Bcl-2 family in which Bax
and Bak confer an essential gateway for the activation of
caspases in this pathway (Ruiz-Vela et al., 2005). Previous
studies suggested that Bax and Bak were functionally redundant
with respect to their role in apoptosis. Cytochrome c release
occurs in Bax−/−Bak+/+ and Bax+/+Bak−/− MEFs but not in
Bax/Bak−/− MEFs during stress-induced cell death (Cheng et
al., 2003; Wei et al., 2001). Hence, deletion of both Bax and
Bak is required to confer resistance to apoptosis induced by
different stimuli (Lindsten et al., 2000; Wei et al., 2001). Based
on a recent model – termed the “switched rheostat” model – the
ratio of anti- to proapoptotic proteins constitutes a balance that
set the threshold of susceptibility to apoptosis for the intrinsic
pathway (Bagci et al., 2006). Activation and oligomerization of
Bax or/and Bak results in permeabilization of the mitochondrial
outer membrane to initiate cytochrome c release and other
cofactors involved in the efficient activation of effector caspases
(Annis et al., 2005; Antonsson, 2001; Korsmeyer et al., 2000).
Based on this model, antiapoptotic Bcl-2 protects cells prin-
cipally by inhibiting mitochondrial permeabilization through
binding and sequestering “BH3-only” activator molecules
(Cheng et al., 2001; Wei et al., 2001).
An earlier report demonstrated that VSV initiated early MMP
leading to cell death (Gadaleta et al., 2005). Caspase 9
activation correlated with the release of both cytochrome c
and AIF from the mitochondrial intermembrane space. Gaddy et
al. also showed that VSV AV1 induced apoptosis via the
extrinsic pathway, distinct from cell death induced through the
intrinsic pathway by wild type VSV (Gaddy and Lyles, 2005).
The inability of the M mutated AV1 virus to inhibit host gene
expression resulted in the activation of all three major initiator
caspases— caspase-8, caspase-9, and caspse-12, as well as the
executioner caspase-3 (Gaddy and Lyles, 2005). Furthermore,
treatment with the caspase-8 inhibitor of cells infected with
VSV-AV1 prevented the activation of caspase-9 but not
caspase-12, indicating that caspase-8 activates caspase-9
(Gaddy and Lyles, 2005). This cross-talk suggests a mechanism
by which VSV-AV1 initially signals through the death receptor
pathway, but ultimately both WT and VSV-AV1 require the
intrinsic mitochondrial pathway to initiate cell death. Recently,
an alternative adaptor protein Daxx was identified as an
important component of apoptosis induced by VSV-AV1 and
Daxx appears to be more important than FADD for apoptosis
induced by VSV-AV1 (Gaddy and Lyles, 2007). Furthermore,
dominant-negative mutants of Fas and PKR inhibited AV1-
induced apoptosis, and Daxx possessed novel functions in the
host response to virus infection by mediating virus-induced
apoptosis (Gaddy and Lyles, 2007).
Our results indicate that Bax represents the convergence
point of VSV-mediated cell death, regardless of the VSV strain:
1) both VSV strains were able to infect, replicate, and kill cells
defective in the extrinsic apoptotic pathway with similar
efficacy; 2) mitochondrial membrane potential loss was
triggered by both strains with similar kinetics, regardless of
Fig. 5. Defective IRF-3 phosphorylation, nuclear translocation, and DNA
binding activity in BaxBak−/− MEF. A: WT or BaxBak−/− MEFs were infected
with VSV-AV1 strain at an MOI of 1 pfu/cell over indicated time points. The
migration pattern of IRF-3 on SDS-PAGE was determined in WCE. The
position of different IRF-3 forms (I, II, III, and IV) are indicated. β-Actin was
included as a loading control. B: WT or BaxBak−/−MEFs were infected as in A.
IRF-3 nuclear translocation was determined in nuclear extract. Total lysates
from VSV-infected WT MEFs were used as a positive control. The position of
activated IRF-3 forms (III, and IV) are indicated. C: IRF-3 binding activity was
analyzed by electrophoretic mobility shift assay (EMSA) in WCE from WT or
BaxBak−/− MEFs infected as in A over indicated time points. The IFN-
stimulated gene 15 response element (ISG15 ISRE) was used as probe. Protein–
DNA complexes corresponding to IRF-3 and IRF-2 are indicated. D:
Densitometric analysis of IRF-3–DNA complex from C is shown. Fluorescence
intensity is demonstrated as arbitrary units. E and F: WT, Bak−/−, or Bax−/−
MEFs were infected with VSV-AV1 strain at an MOI of 1 pfu/cell. Samples were
collected 12 h post infection. IRF-3 DNA binding activity was analyzed by
EMSA in WCE as in C. Specific antibody against IRF-3 or cold probe was used
to identify specific IRF-3–DNA complexes. Protein–DNA complexes corre-
sponding to IRF-3 and IRF-2 are indicated. G: NF-κB DNA binding activity in
WCE was analyzed using kB1 as probe. Specific antibody against NF-κB or
cold probe was used to identify specific NF-κB complexes. Protein–DNA
complexes corresponding to NF-κB are indicated. Results are representative of
three separate experiments.
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strains was comparable in Bid−/− MEFs; and 4) both viruses
failed to induce caspase-3 cleavage in BaxBak−/− MEFs. The
inability of VSV to induce cell death in BaxBak−/− MEFs was
not dependent on the amount of virus, since an MOI of 100 was
still unable to induce cell death, demonstrating a prerequisite of
this intrinsic pathway to trigger efficient apoptosis in infected
cells. Enhanced virus replication and release from infected cells
in BaxBak−/− MEFs (Figs. 3D and E) demonstrate that
disruption of the intrinsic death pathway negatively affected
the full establishment of the antiviral response. In the absence
of Bax/Bak pathway, IRF3 phosphorylation, nuclear trans-
location, and DNA binding were all diminished (Fig. 5).
Knock-down of Bax in A549 cell line resulted in decreased
IRF3 phosphorylation, as well as the enhancement of viral
replication (Fig. 6). Indeed, microarray analysis confirmed a
decreased expression of many immune response genes in
BaxBak−/− MEFs following VSV infection (Figs. 4A and B),
and further implied that the inability to mount a robust
antiviral response increased the permissiveness of BaxBak−/−
MEFs to VSV replication.
A mitochondrial-targeting domain was recently identified in
VSV M protein that mediates the insertion of M into the outer
mitochondrial membrane (Lichty et al., 2006). It is thus
conceivable that the multi-functional M protein not only
inhibits host gene expression but also enhances mitochon-
drial-dependent apoptosis and MMP by interacting with pro-
apoptotic proteins from the mitochondrial intermembrane
space. An understanding of the role of mitochondria in viral
pathophysiology may have important therapeutic implications
for the development of oncolytic viruses; however, a role for
MMP in the regulation of the innate response to virus infection
was unexpected. Viruses have evolved diverse mechanisms to
modulate apoptosis by inhibiting MMP at the beginning of the
virus life cycle or stimulating MMP at the end of infectious life
cycle. Viral control of apoptosis of infected cells at the
mitochondrial level may also represent a defined strategy to
dampen the antiviral response. For example, the hepatitis C
virus NS3-4A protease complex specifically targets MAVS/
IPS-1/VISA/Cardif for cleavage as part of its immune evasion
strategy (Cheng et al., 2006; Lin et al., 2006; Meylan et al.,
2005). Furthermore, the hepatitis C virus NS3-4A protease
disrupts an IFN signaling complex composed of MAVS,
IKKepsilon and potentially other proteins at the mitochondrial
membrane (Lin et al., 2006).
An important determinant in the decision between anti-
viral response or apoptosis may be the recruitment of IKKε
to the mitochondria. Recently, Drosophila IKK-related
kinase (DmIKKε) was shown to function as a regulator of
caspase activation through direct phosphorylation of Droso-
phila inhibitor of apoptosis (DIAP1) (Kuranaga et al., 2006).
IAPs are endogenous caspase inhibitors that block caspase-3, -7
and -9 activity and block the downstream portion of the
apoptosis pathway (Salvesen and Duckett, 2002; Vaux and
Silke, 2005; Zong et al., 2001). Importantly, the human
homologue IKKε phosphorylated XIAP and facilitated its
degradation (Kuranaga et al., 2006), implying that IKKε
Fig. 5 (continued).
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apoptotic response through XIAP phosphorylation and turn-
over. Based on the results of the present study, Bax/Bak
dependent mitochondrial depolarization and the intrinsic death
pathway enhance the full development of an effective antiviral
response (Hiscott et al., 2006a). Ongoing studies are
investigating the relationship between the mitochondrial
apoptotic pathway, RIG-I signaling events and the initiation
of the IFN antiviral response.
Materials and methods
Cell culture
Wild-type MEFS, caspase-9−/−, caspase-2/9−/−, Bak−/−,
Bax−/−, BaxBak−/−, Bid−/−, HEK 293T, and Vero African
green monkey kidney cells were cultured in Dulbecco's modi-
fied Eagle's medium (Wisent INC). Wild-type, caspase-9−/−,
caspase-2/9−/−, Bak−/−, Bax−/−, and BaxBak−/− cells were
derived from C57BL/6 mouse genetic background and
immortalized with SV40 T antigen. Caspase-9−/− and cas-
pase-2/9−/− cells were provided by Dr. Strasser (Marsden et al.,
2004). Bak−/−, Bax−/−, BaxBak−/− and Bid−/− cells were
provided by Dr. Korsmeyer (Wei et al., 2001). The Jurkat
caspase-8−/− and FADD−/− cell lines were provided by Dr. J
Blenis (Juo et al., 1998, 1999) and were cultured in RPMI
1460 (Wisent INC). Both Jurkat caspase-8−/− and FADD−/−cells were generated from a Jurkat T lymphocyte subclone
(A3). The A549 cell line was cultured in F12K media (Wisent
INC). All media were supplemented with 10% heat-
inactivated fetal bovine serum (FBS) plus penicillin/strepto-
mycin (Wisent INC).
Immunoblotting
Total lysates were extracted and Western blot analysis was
performed as previously described (Sharif-Askari et al., 2001).
Briefly, cells were washed with PBS and lysed in lysis buffer
(0.05% NP40, 0.1% glycerol, 30 mM NaF, 40 mM β-
glycerophosphate, 10 mM Na3VO4, 10 ng/ml of protease
inhibitors (leupeptin, aprotinin, pepstatin)). Protein concentra-
tion was determined with Bio-Rad protein assay reagent
(BioRad), and 20 μg of protein was then resolved using 12–
14% SDS-PAGE and transferred to nitrocellulose membrane
(Hybond C Super; Amersham, Oakville, Canada). Blots were
blocked for 1 h at 25 °C in 5% non-fat dried milk in PBST
(PBS+0.5% Tween-20). The following antibodies were used:
rabbit anti-VSV (1:5000), anti-Rho-GDI (BD Pharmigen,
1:5000), anti-procaspase 3 (Upstate, 1:2000), anti-Bax (Santa
Cruz, 1:1000) anti-cleaved caspase 3 (Cell Signaling, 1:2000),
or mouse anti-β actin (Chemicon, 1:1000). For IRF-3
analysis, 40 μg of protein was loaded on 7.5% SDS-PAGE
and immunoblot analysis was performed using rabbit anti-
IRF-3 (Zymed, 1 μg/ml). The immunocomplexes were detected
Fig. 6. Diminished IRF3 phosphorylation and apoptosis in Bax knock-down
cells. A: A549 cells in 6-well plates were transfected with 250 pmol of Bax
siRNA using Lipofecatmine 2000 reagent. Cells were infected with VSV-AV1 at
an MOI of 1 pfu/cell. WCE samples were collected at indicated time points and
ran on SDS-PAGE and immunoblotted against IRF3, VSV, and Bax. β-Actin
was included as a loading control. B: A549 Bax knock-down cells infected with
VSV-AV1 were collected at indicated time points to quantify apoptotic cells by
flow cytometry using Annexin V staining.
Fig. 7. Overexpression of Bax induces IRF-3 binding activity. A: HEK293T
cells were transfected with empty vector or vector expressing murine Bax (2 μg/
60 mm plate). Cell death was monitored microscopically and images were taken
with a 40× objective 48 h post-transfection. B: Cells were collected 48 h post-
transfection and the shift in the mitochondrial transmembrane potential was
quantified by flow cytometry using JC-1 staining. C: IRF-3 DNA binding
activity was analyzed in WCE using the ISG15 ISRE as a probe. Protein–DNA
complexes corresponding to IRF-3 and IRF-2 are indicated. IRF-3 DNA binding
activity of VSV-infected cells was used as positive control. Results are
representative of two separate experiments.
30 E. Sharif-Askari et al. / Virology 365 (2007) 20–33with horseradish peroxidase-conjugated secondary antibodies
and enhanced chemiluminescence (ECL, Amersham
Biosciences).
Virus production, quantification and infection
Wild-type VSV (Indiana serotype), AV1 VSV, and rVSV-
GFP were propagated in Vero cells as described previously
(Stojdl et al., 2003). Viruses were obtained from cell-free
supernatants and titrated on Vero cells by standard plaque assay.
Virus yields were expressed as plaque forming unit (PFU) of
released virus per milliliter. Cells were mock-infected or infected
with VSV virus as previously described (TenOever et al., 2004).
For rVSV-GFP, virus replication was analyzed using inverted
microscopy equipped with UV lamp (Zeiss, Axiovert 25).
Microarray analysis
cDNA preparation and microarray analyses were per-
formed at the LDI Microarray Facility. Total RNA was
extracted with the Qiagen RNeasy RNA isolation kit
(Qiagen), and amplified with the MessageAmp aRNA
amplification kit (Ambion). A second round of amplificationwas performed with the SuperArray TrueLabeling-AMP linear
amplification kit to incorporate biotin-16-UTP (SuperArray).
RNA quality was assessed with the 2100 Bioanalyzer
(Agilent Technologies). The Oligo GEArray mouse interferon
α, β response microarray (SuperArray, OMM-016) was used
for probe hybridization. For each condition, triplicate arrays
were hybridized independently. Numerical data analyses were
performed with the GEArray Analyzer Software (Super-
Array). Briefly, raw signal intensities were corrected for
background by subtracting minimum value, normalized to the
median, and the mean adjusted to value of 100. A gene table
was generated with the average of all replicates per gene.
Ratio of expression levels in WT versus BaxBak−/− MEFs
was generated for all time points and genes differentiating the
31E. Sharif-Askari et al. / Virology 365 (2007) 20–33classes with ratios above 2 were selected as significant. The
Gene table of significant values was imported into Gene-
Traffic Software (Iobion) to permit the simultaneous evalua-
tion of multiple experiments and visualization of coordinate
patterns of gene regulation.
RT-PCR
Whole RNA from treated cells was extracted using Trizol
(Invitrogen) according to the manufacturer's instructions.
RNA purity was analyzed using an Agilent 2100 Bioanalyzer
with the RNA 6000 NanoLabChip (Agilent Technologies).
RT-PCR was performed using 1 μg of RNA resuspended in
RNase-free ddH2O and Oligo dT primer (Clontech) according
to the manufacturer's conditions. Reverse transcription was
performed using Superscript II (Invitrogen) at 42 °C for 1 h.
Following the reverse transcription reactions, cDNA samples
were brought to 100-μl final volumes of which 5 μl was used
as template for each independent PCR with Taq polymerase
(Amersham). The primer sequences used in this study for
PCR were:RANTES, 5′-ATATGGCTCGGACACCACTC-3′
and 5′-TGGGAGTAGGGGATTACTGG-3′; IP-10, 5′-AAG-
TGCTGCCGTCATTTTCT-3′ and 5′-CACTGGGTAAAGGG-
GAGTGA-3′, IFN-β, 5′-CACAGCCCTCTCCATCAACT-3′
and 5′-TCCCACGTCAATCTTTCCTC-3′, IL-6, 5′-ATGAAG-
TTCCTCTCTGCAAGAGACT-3′ and 5′-TCCAGTTTG-
GTAGCATCCATC-3′, IL-15, 5′-CATTTTGGGCTGTGTCA-
GTG-3′ and 5′-TCTCCTCCAGCTCCTCACAT-3′, TNF-α,
5′-AGTCCGGGCAGGTCTACTTT-3′ and 5′-CTCCCTTT-
GCAGAACTCAGG-3′, GAPDH, 5′-AGGAGCGAGAC-
CCCACTAAC-3′ and 5′-GTGGTTCACACCCATCACAA-3′.
All primers were designed using Primer 3 software (Rozen
and Skaletsky, 2000). PCR fragments were amplified at an
annealing temperature of 55 °C for 35 cycles. Products were
run on a 1% agarose gel and revealed through use of a
Typhoon 9400 phosphoimager (Amersham).
Nuclear protein purification
Cells were washed with PBS and cytosolic fraction was
removed by incubating the cells with 100–300 ul TKM buffer
(10 mM Tris (pH 7.6), 10 mM KCl, 5 mM MgCl2, 0.2% NP40,
0.5 mM PMSF, 1 mM DTT, 10 ug/ml Leupeptin) for 15 min on
ice, followed by 5 min of low speed spinning. Palettes were then
washed with cold TKM buffer and lysed for 5 min on ice with
nuclear lysis buffer (0.05% NP40, 0.1% glycerol, 30 mM NaF,
40 mM β-glycerophosphate, 10 mM Na3VO4, 10 ug/ml of
protease inhibitors). Following 3 times of freeze and thaw,
nuclear extracts were collected after 30 min spinning at
13,000 rpm. Protein concentration was determined with Bio-
Rad protein assay reagent (BioRad), and 100 μg of protein was
then resolved using 7.5% SDS-PAGE.
Electrophoretic mobility shift assay (EMSA)
Whole-cell extracts prepared from MEFs as detailed above
were subjected to EMSA using γ-32P-labeled probes. Thebinding reaction was carried out in a 20-μl final volume in
binding buffer containing 20 mM HEPES (pH 7.9), 5%
glycerol, 0.1 M KCl, 0.2 mM EDTA (pH 8), 0.2 mM EGTA
(pH 8), and 1 μg of poly(dI–dC) using 20 μg protein extract
from the indicated cells. The following oligonucleotide probes
were used: IRF-3, 5′-GATCGGGAAAGGGAAACCGA-
AACTGAAGCC-3′ κB1, 5′-CTCTGCAAAGCGAAGTCCC-
CTTCGCAC-3′.
Protein/DNA complexes were resolved on 5% polyacryla-
mide–0.5× Tris–borate–EDTA gels and exposed to Biomax
XR film (Kodak) overnight at −80 °C. Supershift analysis was
performed for 15 min at room temperature using 1 μg of anti-
IRF-3, or anti-p65 (Santa Cruz Biotechnology).
Measurement of apoptosis
Apoptotic cells were quantified by Annexin V/propidium
iodide (PI) double staining for detection of the apoptotic plasma
membrane (phosphatidylserine translocation) (54). The percen-
tage of nuclei with subdiploid DNA content (sub-G1 DNA) was
determined by PI staining as described (Ren et al., 2004). The
Mitochondrial transmembrane potential (Δψm) was examined
by staining cells with JC-1 reagent (Molecular Probes), ac-
cording to the manufacturer's protocol.
RNAi
Bax siRNA for the inhibition of Bax expression in human
cells was purchased from Santa Cruz (sc-29212), along with
fluorescein conjugated control siRNA (sc-36869). Briefly,
siRNA oligos at a final concentration of 250 pmol were
transfected into A549 cells using lipofectamine 2000 reagent
(Invitrogen). This transfection procedure was repeated on the
second day to increase RNAi efficiency. On the third day, cells
were infected with VSV-AV1 at an MOI of 1 pfu/cell and cells
were harvested by trypsinization at the indicated time points.
Measurement of caspase-3 activity
DEVDase assay was performed following the manufac-
turer's instructions (Biomol, Plymouth, PA). Briefly, cells were
infected with VSV-AV1 or VSV-HR for 12 and 24 h, harvested
by trypsinization, and then lysed with lysis buffer provided in
the kit (supplemented with 0.1% Triton X-100). The assay is
based on the cleavage of the substrate DEVD bonded to the
chromophore p-nitroanilide (pNA), which is measured by
reading the absorbance (at 405-nm wavelength) of the samples
(maintained at 37 °C) at 15-min increments for 90 min. The
protein content was determined by Bradford assay. The rate of
cleavage of pNA pmol/min/μg of protein allows for calculation
of specific activity.
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